Portman Square Capital LLP Viatris Inc Transaction History
Portman Square Capital LLP
- $2.72 Billion
- Q2 2024
A detailed history of Portman Square Capital LLP transactions in Viatris Inc stock. As of the latest transaction made, Portman Square Capital LLP holds 599,800 shares of VTRS stock, worth $7 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
599,800
Previous 24,904
2308.45%
Holding current value
$7 Million
Previous $297,000
2046.46%
% of portfolio
0.23%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.64 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.08 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$725 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$671 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$663 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...